久久亚洲av成人出白浆,日日添夜夜添夜夜添爱欧美,真人视频gif无码专区,日日操夜夜操狠狠操麻豆

產(chǎn)品與服務(wù)
聯(lián)系我們
公司名稱:廣州健侖生物科技有限公司
地址:廣東省廣州市番禺區(qū)石樓鎮(zhèn)清華科技園創(chuàng)啟路63號A2棟101
郵編:510660
聯(lián)系人: 楊永漢
傳真:86-020-32206070
E-mail: service@jianlun.com
產(chǎn)品展示
您現(xiàn)在的位置:首頁 > 產(chǎn)品中心 > 檢測試劑 > 尼古丁檢測試劑 > 40T診斷違禁品試劑杯-MOMC
40T診斷違禁品試劑杯-MOMC

40T診斷違禁品試劑杯-MOMC

型    號:
報    價:
分享到:

40T診斷違禁品試劑杯-MOMC:我司同時有bzo - bar - coc - thc met - - opi - oxy - mdma - cfp - amp - xtc – bat多聯(lián)檢測卡(膠體金法)

  • 產(chǎn)品描述

                                  40T診斷違禁品試劑杯-MOMC                                 

INTENDED USE

Multi DOA Screen Panel are rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to fourteen of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:

 

Parameter

Calibrator

Cut-off(ng/mL)

THC

11-nor-D9-THC-9-COOH

50 ng/ml

COC

Benzoylecgonine

300 ng/ml

PCP

Phencyclidine

25 ng/ml

OPI

Morphine

2000 ng/ml

MET

Methamphetamine

1000 ng/ml

MTD

Methadone

300 ng/ml

AMP

Amphetamine

1000 ng/ml

BAR

Secobarbital

300 ng/ml

BZO

Oxazepam

300 ng/ml

TCA

Nortriptyline

1000 ng/ml

MDMA

3,4-Methylenediioxy-MET

500 ng/ml

BUP

BUP-3-D-Glucuronide

10 ng/ml

EDDP

EDDP

100 ng/ml

OPI/MOR

Morphine

300 ng/ml

KET

Ketamine 

1,000ng/ml

TML

Cis-Tramadol 

100ng/ml

OXY

Oxycodone

100ng/ml

PPX

Propoxyphene

300ng/ml

K2

JWH-073/JWH-01

50 ng/ml

FYL

*

200 ng/ml

COT

Cotinine

200 ng/ml

ALC

Alcohol

 

 

The test is used to obtain visual qualitative result and is intended for health care professionals use including professionals at point of care sites to assist in the determination of drug compliance. It is not intended for over the counter sale to non-professionals.

This assay provided only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/ Mass Spectrometry (GC/MS) or Liquid Chromatography/ Mass Spectrometry (LC/MS) are the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

INTRODUCTION

Urine based screening tests for drugs of abuse range from simple immunoassay tests to complex analytical procedures. The speed and sensitivity of immunoassays have made them the most widely accepted method for screening urine for drugs of abuse.

The DOA Panels are based on the principle of the highly specific immunochemical reactions of antigens and antibodies, which are used for the analysis of specific compounds in human urine. The DOA Screen Panels are rapid, visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of 11-nor-D9-tetrahydrocannabinol-9-carboxylic acid, Benzoylecgonine, Phencyclidine, Morphine, Methadone, Methamphetamine, Amphetamine, Barbiturates, Oxazepam, Nortriptyline, MDMA, ,Ketamine,Buprenorphine-3-D-Glucuronide, Tramadol and EDDP in urine. The length of time following drug use for which a positive result may occur is dependent upon several factors including the frequency and amount of drug, metabolic rate, excretion rate, drug half-life, and the drug user’s age, weight, activity and diet.

PRINCIPLE

The DOA Panels are one-step immunoassay in which chemically labeled drugs (drug-protein conjugates) compete for limited antibody binding sites with drugs which may be present in urine. The test device contains membrane strips which are pre-coated with drug-protein conjugates on the test band(s). Each strip, the drug antibody-colloidal gold conjugate pad is placed at one end of the membrane. In the absence of drug in the urine, the solution of the colored antibody-colloidal gold conjugate move along with the sample solution upward chromatographically by capillary action across the membrane to the immobilized drug-protein conjugate zone on the test band region. The colored antibody-gold conjugate then attach to the drug-protein conjugates to form visible lines as the antibody complex with the drug conjugate. Therefore, the formation of the visible precipitant in the test zone occurs when the test urine is negative for the drug. When the drug is present in the urine, the drug/metabolite antigen competes with drug-protein conjugate on the test band region for the limited antibody.  When a sufficient concentration of the drug is present, it will fill the limited antibody binding sites. This will prevent attachment of the colored antibody (drug-protein conjugate)-colloidal gold conjugate to the drug-protein conjugate zone on the test band region. Therefore, absence of the color band on the test region indicates a positive result.

A control band with a different antigen/antibody reaction is added to the immunochromatographic membrane strip at the control region (C) to indicate that the test has performed properly. This control line should always appear regardless of the presence of drug or metabolite. If the control line does not appear the test device should be discarded. 

添加掃一掃二維碼:

【公司名稱】 廣州健侖生物科技有限公司

【市場部】       楊永漢
【】 
【騰訊 】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號二期2幢101-103室

廣州健侖生物科技有限公司(www.trqcyp.com) 熱門產(chǎn)品:喹諾酮類檢測試劑盒,西尼羅河檢測試劑,基孔肯雅熱試劑,寨卡檢測試劑,疫病核酸試劑
地址:廣東省廣州市番禺區(qū)石樓鎮(zhèn)清華科技園創(chuàng)啟路63號A2棟101 Email:service@jianlun.com
ICP備:粵ICP備11063766號 GoogleSitemap 技術(shù)支持:化工儀器網(wǎng) 管理登陸 返回首頁
狠狠躁夜夜躁av网站色| 国产在线视频一区二区三区| 国产97在线 | 日韩| 一天不日就痒痒| 婷婷俺也去俺也去官网| 久久久久噜噜噜亚洲熟女综合 | 国产97在线 | 免费| 亚洲国产成人精品女人久久久| 色偷偷AV老熟女色欲涩爱| 国产L精品国产亚洲区久久| 旧里番-[3d]怪物蹂躏美女| 玩小雪跪趴把腿分到最大影视 | 国产午夜精品一区二区三区| 黑人大战中国av女叫惨了| 夜色福利站www国产在线观看| 久久精品国产96精品亚洲| 50厘米全进去XXXX猛交| 亚洲日韩av无码精品放毛片 | 婷婷色啪啪色窝窝一区| 色欲麻豆国产福利精品| 国产做A爱免费视频在线观看| 果冻传媒AV毛片无码蜜桃| 亚洲小说区图片区另类春色| 午夜欧美精品久久久久久久| 中文字幕色AV一区二区三区| 精品人体无码一区二区三区| y111111少妇影院无码| ASSFREE疯狂老妇熟女| 饭桌上故意张开腿让公| 国产成人精品999在线观看 | 婷婷国产偷V国产偷V亚洲高清| 久久久无码一区二区三区| 亚洲国产精品一区二区www| 日本理伦片午夜理伦片| 久久AV无码精品人妻糸列| 交换娇妻系列38部分阅读| 好爽…又高潮了毛片喷水| 女人高潮抽搐潮喷WWW| 成人夜色视频网站在线观看| 深田えいみ禁欲后被隔壁人妻| 老公的朋友跟我做完就不理我了|